Concepedia

Lydia Gedmintas

LG

Statistics

Publications

10

Citations

789

H-Index

10

Active since

2013

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Boston University

Johns Hopkins University

Lydia Gedmintas is an author at Brigham and Women's Hospital specializing in medicine, autoimmune disease, and rheumatology.

Top concepts

Publications per year

2013–2023

10

Publications

10

Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders

Giulia C. Leonardi, Justin F. Gainor, Mehmet Altan et al. · Journal of Clinical Oncology · 2018 · 351 citations · Full text

, , +20

Drug‐Associated Polymyalgia Rheumatica/Giant Cell Arteritis Occurring in Two Patients After Treatment With Ipilimumab, an Antagonist of CTLA‐4

Barbara L. Goldstein, Lydia Gedmintas, Derrick J. Todd · Arthritis & Rheumatology · 2013 · 185 citations

, , +8

Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis

Anne R. Bass, Noha Abdel‐Wahab, Pankti Reid et al. · Annals of the Rheumatic Diseases · 2023 · 64 citations · Full text

Rheumatologic symptoms in oncologic patients on PD-1 inhibitors

Wilson Kuswanto, Lindsey A. MacFarlane, Lydia Gedmintas et al. · Seminars in Arthritis and Rheumatism · 2017 · 57 citations

, , +7

Predictors of Rheumatic <scp>Immune‐Related</scp> Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer

Amy Cunningham‐Bussel, Jiaqi Wang, Lauren Prisco et al. · Arthritis & Rheumatology · 2021 · 40 citations · Full text

1–5 of 10